Efficacy of encainide in supraventricular arrhythmias
β Scribed by Peter E. Pool
- Publisher
- Springer US
- Year
- 1990
- Tongue
- English
- Weight
- 464 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0920-3206
No coin nor oath required. For personal study only.
β¦ Synopsis
This review summarizes the data from all the studies conducted in the United States and Europe that have evaluated the efficacy of encainide in patients with a variety of supraventricular arrhythmias. Using clinical criteria of efficacy, encainide was found to be effective or partially effective in 77% of patients evaluated by electrophysiologic means. Similar levels of efficacy were observed in patients with AV as well as AV nodal reentry arrhythmias. Patients with other forms of supraventricular arrhythmias in smaller series also experienced comparable degrees of efficacy. Encainide was discontinued because of intolerance by 8% of the patients in these studies: 6% because of side effects and 2% because of proarrhythmia.
π SIMILAR VOLUMES
Drug Treatment of Supraventricular Arrhythmias P125 FLEΒ£,AINIDE (F) ~N) I:~P~ENONE (P) 1N ]HE ]W:A'Ii,ENT OF [email protected]~. All~Lq\_ FIBRILLATION (P~). M.Balducelli,~.Fab~,A.i~aresta, Oepar~ of Caroiology, Ospedale per gli Infermi, F)~B~.A, IT&Y. ~ehaserar~4bpatients with recent omet PAF to trea~mmt
Sotalol has a virtually unique antiarrhythmic profile in that it combines the properties of the Class II betablocking agents with the Class III properties that prolong repolarization. The Class II action exerts a marked effect on atrioventricular nodal conduction and makes sotalol a suitable drug fo